Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 114

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 114
---
Asia Pacific.

NewGenIvf is still in the
early stage of materializing its long-term objective of building a comprehensive, sophisticated and high-end ARS platform for its clients
and providing personalized solutions based on NewGenIvf’s brands and client-generated services. NewGenIvf plans to offer full fertility
services for fertility tourists across Asia Pacific, continue to invest in laboratories and facilities updates, increase its brand awareness
and market share, as well as expand service reach through acquisitions and partnerships, which NewGenIvf believes will help expand its
client base and enhance expertise attraction, and in turn strengthen NewGenIvf’s monetization capabilities.

Key Factors Affecting NewGenIvf’s Results of Operations

NewGenIvf’s results
of operation are principally affected by the following factors:

Regulatory environment

The ARS market in Asia-Pacific
region is highly regulated. The implementation and enforcement of laws, regulations and government policies in Thailand, Cambodia, Kyrgyzstan
and other applicable jurisdictions significantly impact the design, pricing and sale of fertility services and cost of compliance for
clinics across Asia Pacific. Medical facilities providing fertility services generally must be filed and registered with the relevant
supervision institutions and such filing and registration must be renewed periodically. Any change in laws, regulations or policies in
relation to such filing or registration could affect NewGenIvf’s ability and plans to launch new services and renew registration
for existing services. The regulatory framework for medical facilities and services, especially those involving ARS, is, and will continue,
evolving. Any changes in the applicable regulatory frameworks in the jurisdictions where NewGenIvf operates may materially affect its
financial condition and results of operations.

<div align='center'>65</div>

Growth and competitive landscape of Asia Pacific’s ARS market

NewGenIvf’s revenue
has historically been primarily derived from clients in Asia Pacific. As such, NewGenIvf’s financial performance and future growth
depend primarily on the demand for ARS, as well as changes in its competitive landscape, in Asia Pacific. Population growth, infertility
rates, and demand for facility treatments in the region will ultimately determine the demand for NewGenIvf’s services. According
to CIC, infertility is increasingly becoming prevalent globally, primarily driven by increasing average age of first birth, as well as
various lifestyle and environmental factors. Driven by an increased infertility rate and growing demand for children without birth defects,
resulting from improving living standards and improved awareness about birth defects